Advertisement

SFE

Safeguard Scientifics, Inc.

Financial Services

Set alert

Price alert · SFE

All alert types
0.46 0.00 0.00%
As of Feb 9, 2024
0.4004 Day range 0.685

52-week range unavailable

Open
0.65
Prev close
0.455
Mkt cap
7.54M
Vol
899.34K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.4004
High
0.685
Forward P/E
-0.49
Beta
0.87
Short ratio
3.50
Inst. own
45.02%
Dividend
0.00
Ex-div date
Dec 28, 2023
Earnings
Mar 14, 2024
50-d avg
0.753587
200-d avg
1.14
1y target
0.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for SFE has not been loaded yet. Try again in a moment.

Key statistics

Market cap
7.54M
Enterprise value
-4.60M
Trailing P/E
0.00
Forward P/E
-0.49
PEG ratio
0.00
Price / sales
0.00
Price / book
0.25
EPS (TTM)
-0.63
Beta
0.87
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-1.11M
Total cash
15.66M
Total debt
1.36M
Return on equity
-29.38%
Shares outstanding
16.58M
Short % of float
1.62%
50-day average
0.753587
200-day average
1.14

Analyst view

Consensus: buy

Buy
Price target (mean) 0.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Mar 14, 2024

Expected Mar 14, 2024. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
SFE Revenue — quarterly 0
2019-12-312020-03-312020-06-302020-09-302020-12-312021-03-312021-06-302021-09-302021-12-312022-03-312022-06-302022-09-302022-12-312023-03-312023-06-302023-09-30
SFE Net income — quarterly 932.00K
2019-12-312020-03-312020-06-302020-09-302020-12-312021-03-312021-06-302021-09-302021-12-312022-03-312022-06-302022-09-302022-12-312023-03-312023-06-302023-09-30
SFE EPS — quarterly 0.06
2019-12-312020-03-312020-06-302020-09-302020-12-312021-03-312021-06-302021-09-302021-12-312022-03-312022-06-302022-09-302022-12-312023-03-312023-06-302023-09-30

Earnings

SFE recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Mar 14, 2024Dec 1, 20230.00———
Nov 2, 2023Sep 1, 20230.00———
Aug 10, 2023Jun 1, 20230.00———
May 4, 2023Mar 1, 20230.00———
Mar 9, 2023Dec 1, 20220.00———
Nov 3, 2022Sep 1, 20220.00———

Upgrades / downgrades

SFE analyst upgrades and downgrades
DateFirmActionFromTo
Jul 26, 2018First AnalysisdownOverweightEqual-Weight
Oct 25, 2015Keefe, Bruyette & Woodsmain—Outperform
Jul 20, 2015Barrington Researchinit—Outperform
Mar 5, 2015Keefe, Bruyette & Woodsmain—Outperform
Jul 27, 2014First AnalysisupEqual-WeightOverweight
May 12, 2014First AnalysisdownOverweightEqual-Weight

About Safeguard Scientifics, Inc.

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.

Sector
Financial Services
Industry
Asset Management
Country
United States

News

Your note

Sign in to keep a note on SFE — it syncs with the Stock Master app.

Insider holders

SFE insider holders
InsiderRelationLatest transactionDateShares held
DEMONT ROSS D.DirectorStock Award(Grant)Jan 29, 2024630,978
GLASS RUSSELL DDirectorStock Award(Grant)Jan 29, 2024186,400
HERNDON MARK A.Chief Financial OfficerStock Award(Grant)Jan 16, 202357,469
MANKO JOSEPH M JRDirectorStock Award(Grant)Jan 29, 2024409,709
MICHELSON BETH S.DirectorStock Award(Grant)Jan 29, 2024126,352
MORRISON MAUREEN FDirectorStock Award(Grant)Apr 16, 2023100,615

Institution ownership

SFE institution ownership
Holder% heldSharesValueReported
Contrarian Capital Management, LLC7.32%1,199,2041.98MJun 29, 2023
Yakira Capital Management, Inc.7.11%1,164,9451.92MJun 29, 2023
First Manhattan Company4.89%800,8961.32MJun 29, 2023
Almitas Capital LLC4.86%796,6321.31MJun 29, 2023
Vanguard Group Inc4.23%692,9231.14MJun 29, 2023
CM Management, LLC4.10%671,6711.11MJun 29, 2023

Fund ownership

SFE fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.55%417,279688.51KJun 29, 2023
Vanguard Extended Market Index Fund1.45%237,965392.64KJun 29, 2023
Fidelity Extended Market Index Fund0.56%92,152162.19KMay 30, 2023
DFA U.S. Micro Cap Series0.41%66,747102.79KJul 30, 2023
Bridgeway Funds Inc-Ultra Small Company Market Fund0.37%60,50099.83KJun 29, 2023
DFA U.S. Core Equity 2 Portfolio0.32%52,10580.24KJul 30, 2023
Advertisement